ORIC Pharmaceuticals, Inc. (ORIC): Projected Future Earnings

ORIC Pharmaceuticals develops combination therapies to overcome tumor resistance. The asset remains independent of macroeconomic trends, relying instead on patents and biological data. Close partnerships with pharmaceutical behemoths serve as the primary driver. The company's future profit projections clearly demonstrate the dynamics of market expectations, with representing the final metric reading.

ORIC - oricpharma.com Expected Net Profit over the range 07/04/2022 - 11/12/2026

Financial and market metric breakdowns for ORIC Pharmaceuticals Inc (ORIC)

- price and consensus price forecast:

Price Chart ORIC Pharmaceuticals|ORIC - Average Forecast Price

- stock exchange capitalization data:

Market Capitalization ORIC Pharmaceuticals|ORIC - Full Takeover Company Value

- book capitalization indicators:

Accounting Value per Share ORIC Pharmaceuticals|ORIC - Total Stockholders' Equity|Market Cap to Net Assets Ratio oricpharma.com|ORIC - Aggregate Asset Value

- debt level and financial liquidity data:

- earnings and market ratios statistics:

ORIC - Company Net Income|Future Profit ORIC Pharmaceuticals|ORIC - Market Price to Net Income Ratio|Forward P/E Multiple ORIC Pharmaceuticals, Inc.|ORIC - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple ORIC Pharmaceuticals|ORIC - Operating profit before amortization|Net earnings per share for the last 12 months ORIC Pharmaceuticals|ORIC - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months oricpharma.com|ORIC - Net earnings per one share growth for the current year|Earnings growth forecast for next year ORIC Pharmaceuticals

Basic company analysis:ORIC, ORIC Pharmaceuticals

Selecting undervalued assets requires analyzing future cash flow dynamics to rule out systemic business decline. This indicator measures a company's expected efficiency and identifies reversals in fundamental trends, which, for ORIC Pharmaceuticals (ORIC), given its clinical trial transparency and strict capital discipline, confirms a strategic management adaptation reflected in the company's forward earnings movement.

Competitor analysis for ORIC Pharmaceuticals